News
HotCopper on MSN3h
Nyrada pushes through to third cohort in Phase 1 trial for NYR-BI03Nyrada Inc (ASX:NYR) is set to progress to the third cohort in its Phase 1 clinical trial assessing the safety, tolerability ...
LONDON, April 29, 2025 (GLOBE NEWSWIRE) -- Following MHRA approval, Stablepharma Ltd has commenced a Phase 1 clinical trial with its lead candidate, fridge-free tetanus and diphtheria vaccine ...
ImmunoGenesis, a clinical-stage biotechnology company developing innovative, science-driven immune therapies, and Cancer ...
Stockhead on MSN6h
Race Oncology doses first patient in RC220 Phase 1 solid tumour trialRace Oncology has begun dosing patients in a Phase 1 clinical trial assessing RC220 in solid tumours ... Read More The post ...
Y-mAbs Therapeutics, Inc. announced that the first patient has been dosed in its Phase 1 clinical trial (Trial 1201) for evaluating the company’s Self-Assembly and Disassembly (SADA) Pre ...
Interim safety data from the first-in-human Phase 1 clinical trial of CMP-CPS-001 underscores the company’s commitment to transparency and regulatory compliance in clinical research. Three oral ...
AVB-101 Biomarker Data Readout Expected in 2026 Clinical Milestone Shared at AFTD Annual Caregiver Conference AviadoBio, a pioneering gene therapy company dedicated to developing and delivering ...
LONDON, April 29, 2025 (GLOBE NEWSWIRE) -- Following MHRA approval, Stablepharma Ltd has commenced a Phase 1 clinical trial with its lead candidate, fridge-free tetanus and diphtheria vaccine, SPVX02.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback